BG108424A - Pyrrolidineoxadiazole and pyrrolidinethiadiazole derivatives - Google Patents

Pyrrolidineoxadiazole and pyrrolidinethiadiazole derivatives

Info

Publication number
BG108424A
BG108424A BG108424A BG10842403A BG108424A BG 108424 A BG108424 A BG 108424A BG 108424 A BG108424 A BG 108424A BG 10842403 A BG10842403 A BG 10842403A BG 108424 A BG108424 A BG 108424A
Authority
BG
Bulgaria
Prior art keywords
compounds
well
derivatives
relates
pyrrolidinethiadiazole
Prior art date
Application number
BG108424A
Other languages
Bulgarian (bg)
English (en)
Inventor
Matthias Schwarz
Anna Quattropani
Patrick Page
Russell Thomas
Vincent Pomel
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of BG108424A publication Critical patent/BG108424A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BG108424A 2001-06-18 2003-12-08 Pyrrolidineoxadiazole and pyrrolidinethiadiazole derivatives BG108424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18

Publications (1)

Publication Number Publication Date
BG108424A true BG108424A (en) 2005-03-31

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108424A BG108424A (en) 2001-06-18 2003-12-08 Pyrrolidineoxadiazole and pyrrolidinethiadiazole derivatives

Country Status (27)

Country Link
US (2) US7115639B2 (pt)
EP (1) EP1444225B1 (pt)
JP (1) JP4426284B2 (pt)
KR (1) KR20040030678A (pt)
CN (1) CN100564378C (pt)
AR (1) AR036108A1 (pt)
AU (1) AU2002319237B2 (pt)
BG (1) BG108424A (pt)
BR (1) BR0211030A (pt)
CA (1) CA2449578C (pt)
CZ (1) CZ20033475A3 (pt)
EA (1) EA006212B1 (pt)
EE (1) EE200400022A (pt)
ES (1) ES2397305T3 (pt)
HK (1) HK1074204A1 (pt)
HR (1) HRP20031017A2 (pt)
HU (1) HUP0400238A2 (pt)
IL (1) IL159219A0 (pt)
MX (1) MXPA03011441A (pt)
MY (1) MY128890A (pt)
NO (1) NO20035399L (pt)
PL (1) PL367275A1 (pt)
RS (1) RS99503A (pt)
SK (1) SK15552003A3 (pt)
UA (1) UA75145C2 (pt)
WO (1) WO2002102799A2 (pt)
ZA (1) ZA200309402B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159219A0 (en) 2001-06-18 2004-06-01 Applied Research Systems Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
WO2004076407A2 (en) * 2003-02-27 2004-09-10 Applied Research Systems Ars Holding N.V. Pyrrolidine derivatives as oxytocin antagonists
SI1725526T1 (sl) * 2004-02-26 2008-04-30 Serono Lab Postopek priprave pirolidoin-oksimov
KR101386494B1 (ko) 2005-05-10 2014-04-24 인사이트 코포레이션 인돌아민 2,3-디옥시게나제의 조절제 및 이의 사용방법
JP5294874B2 (ja) 2005-12-20 2013-09-18 インサイト・コーポレイション インドールアミン２，３−ジオキシゲナーゼのモジュレーターとしてのｎ−ヒドロキシアミジノヘテロ環
WO2008036642A2 (en) 2006-09-19 2008-03-27 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
KR101649548B1 (ko) 2008-07-08 2016-08-19 인사이트 홀딩스 코포레이션 인돌아민 ２,３-디옥시게나아제의 억제제로서의 １,２,５-옥사디아졸
EP2845850A1 (en) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
MX366874B (es) 2013-11-08 2019-07-29 Incyte Holdings Corp Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa.
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
MX371068B (es) 2014-07-02 2020-01-15 ObsEva SA ((3z,5s)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil ]pirrolidin-3-ona o-metiloxima cristalina y métodos de uso de la misma.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
EP0805681A4 (en) 1995-01-24 1998-05-06 Merck & Co Inc TOCOLYTIC ANTAGONISTS OF OXYTOCIN RECEPTORS
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
JP2002543129A (ja) 1999-05-05 2002-12-17 メルク エンド カムパニー インコーポレーテッド 抗微生物剤としての新規なプロリン類
BR0109900A (pt) 2000-03-27 2003-06-03 Applied Research Systems Derivados de pirolidina farmaceuticamente ativos, uso de derivados de pirolidina, composição farmacêutica e processo para preparação de um derivado de pirolidina
IL151911A0 (en) * 2000-03-27 2003-04-10 Applied Research Systems Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
DE60141849D1 (de) * 2000-10-17 2010-05-27 Merck Serono Sa Coinsins Pharmazeutisch aktive sulfonamid-derivate
AU2002256685B2 (en) * 2001-03-20 2008-01-24 Merck Serono Sa Pyrrolidine ester derivatives with oxytocin modulating acitvity
IL159219A0 (en) 2001-06-18 2004-06-01 Applied Research Systems Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
ES2249636T3 (es) * 2001-12-20 2006-04-01 Applied Research Systems Ars Holding N.V. Triazoles como antagonistas de la oxitocina.
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
JP4426284B2 (ja) 2010-03-03
NO20035399L (no) 2004-02-17
CA2449578C (en) 2011-12-13
US20040220238A1 (en) 2004-11-04
RS99503A (en) 2006-12-15
KR20040030678A (ko) 2004-04-09
WO2002102799A3 (en) 2003-04-03
ES2397305T3 (es) 2013-03-06
HUP0400238A2 (hu) 2004-07-28
EP1444225A2 (en) 2004-08-11
US20060229343A1 (en) 2006-10-12
CZ20033475A3 (en) 2004-05-12
MXPA03011441A (es) 2004-07-01
AU2002319237B2 (en) 2008-01-03
CA2449578A1 (en) 2002-12-27
HK1074204A1 (en) 2005-11-04
MY128890A (en) 2007-02-28
BR0211030A (pt) 2004-06-22
IL159219A0 (en) 2004-06-01
EE200400022A (et) 2004-04-15
NO20035399D0 (no) 2003-12-04
US7115639B2 (en) 2006-10-03
UA75145C2 (en) 2006-03-15
AR036108A1 (es) 2004-08-11
ZA200309402B (en) 2004-12-03
EA200400049A1 (ru) 2004-08-26
CN100564378C (zh) 2009-12-02
CN1639155A (zh) 2005-07-13
HRP20031017A2 (en) 2004-04-30
WO2002102799A2 (en) 2002-12-27
SK15552003A3 (sk) 2004-05-04
EA006212B1 (ru) 2005-10-27
JP2004534804A (ja) 2004-11-18
EP1444225B1 (en) 2012-10-10
PL367275A1 (en) 2005-02-21

Similar Documents

Publication Publication Date Title
IL155333A0 (en) Sulfanilide derivatives for use in medicine, certain such new derivatives and their preparation
TW200745111A (en) New compounds
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
SE0104340D0 (sv) New compounds
TW200606164A (en) New compounds
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
WO2003048164A3 (en) Adenosine a2a receptor antagonists
BG108424A (en) Pyrrolidineoxadiazole and pyrrolidinethiadiazole derivatives
JP2002540156A (ja) 抗ウイルス治療用チアジアゾリルウレアまたはチオウレア誘導体
ZA200408283B (en) 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardivascular or rental diseases
CA2468649A1 (en) Adenosine a2a receptor antagonists
SE9901573D0 (sv) New compounds
TW200800984A (en) New compounds
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
SE0104331D0 (sv) Novel compounds
AU2002359162A1 (en) Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
UA74362C2 (uk) Фармацевтично активні похідні піролідину
HUP0400553A2 (hu) Gyógyászati készítmények
SE0102440D0 (sv) New compound
SI1458381T1 (sl) Triazoli kot oksitocinski antagonisti
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
SE9901572D0 (sv) New compounds
EP1613328B8 (en) Use of carbamazepine derivatives for the treatment of agitation in dementia patients
EE200200660A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
AP9801417A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.